|
|
||||||||
1 Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115; and 2 Division of Digestive Diseases, University of Cincinnati Medical Center, Cincinnati, Ohio 45267
Apolipoprotein D (apo D) is a 30-kDa glycoprotein of unknown
function that is associated with high-density lipoproteins (HDL). Because unconjugated bilirubin has been shown to bind apo D with a
0.8:1 stoichiometry, we examined the contribution of this protein to
transport of bilirubin in human plasma. Density gradient centrifugation analysis using physiological concentrations of
[14C]bilirubin reveals that 9% of unconjugated bilirubin
is associated with HDL, with the remaining pigment bound primarily to
serum proteins (i.e., albumin). The percentage of total plasma
bilirubin bound to HDL was found to increase proportionally with
bilirubin concentration. Affinity of human apo D for bilirubin was
determined by steady-state fluorescence quenching, with Scatchard
analysis demonstrating a single binding site for unconjugated bilirubin with an affinity constant (Ka) of ~3 × 107 M
1. Incorporation of apo D into
phosphatidylcholine vesicles had no effect on
Ka, suggesting that a lipid environment does not alter the affinity of the protein for bilirubin. Using stopped-flow techniques, the first-order rate constant for bilirubin dissociation from apo D was measured at 5.4 s
1 (half-time = 129 ms). Our findings indicate that HDL is the principal nonalbumin
carrier of bilirubin in human plasma and further support the
proposition that the affinity of HDL for bilirubin is primarily the
result of binding to apo D.
high-density lipoproteins; human serum albumin; dissociation rate; cholesterol; cholic acid
This article has been cited by other articles:
![]() |
R. P. Wennberg, C. E. Ahlfors, V. K. Bhutani, L. H. Johnson, and S. M. Shapiro Toward Understanding Kernicterus: A Challenge to Improve the Management of Jaundiced Newborns Pediatrics, February 1, 2006; 117(2): 474 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vitek Impact of Serum Bilirubin on Human Diseases Pediatrics, May 1, 2005; 115(5): 1411 - 1412. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |